Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 13 | 2026 | 993 | 2.810 |
Why?
|
| Gene Silencing | 9 | 2026 | 439 | 2.040 |
Why?
|
| Nucleic Acids | 6 | 2024 | 67 | 1.470 |
Why?
|
| Albumins | 4 | 2026 | 46 | 1.380 |
Why?
|
| Dendrimers | 1 | 2026 | 14 | 0.970 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2026 | 154 | 0.960 |
Why?
|
| Myostatin | 1 | 2025 | 20 | 0.920 |
Why?
|
| Central Nervous System | 1 | 2026 | 205 | 0.840 |
Why?
|
| Myocardium | 1 | 2025 | 302 | 0.790 |
Why?
|
| Skin | 1 | 2026 | 436 | 0.730 |
Why?
|
| Polymers | 3 | 2025 | 332 | 0.660 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 789 | 0.620 |
Why?
|
| Nanotechnology | 4 | 2025 | 139 | 0.510 |
Why?
|
| Drug Carriers | 1 | 2019 | 190 | 0.500 |
Why?
|
| DNA | 5 | 2025 | 853 | 0.460 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2026 | 281 | 0.340 |
Why?
|
| Mice | 8 | 2026 | 11185 | 0.310 |
Why?
|
| Animals | 10 | 2026 | 21493 | 0.310 |
Why?
|
| Oligonucleotides | 3 | 2023 | 229 | 0.300 |
Why?
|
| Janus Kinase 1 | 2 | 2026 | 17 | 0.290 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2026 | 18 | 0.240 |
Why?
|
| Nanostructures | 3 | 2025 | 187 | 0.240 |
Why?
|
| Injections, Intradermal | 1 | 2026 | 12 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2026 | 25 | 0.240 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2026 | 72 | 0.230 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2026 | 61 | 0.220 |
Why?
|
| Swine | 1 | 2026 | 398 | 0.220 |
Why?
|
| RNA Interference | 3 | 2026 | 647 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2026 | 216 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 203 | 0.200 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2023 | 20 | 0.200 |
Why?
|
| Heart | 1 | 2025 | 298 | 0.200 |
Why?
|
| Rats | 1 | 2026 | 2005 | 0.190 |
Why?
|
| Glioblastoma | 1 | 2024 | 161 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 2 | 2026 | 3506 | 0.170 |
Why?
|
| Vitiligo | 1 | 2023 | 120 | 0.170 |
Why?
|
| Humans | 13 | 2026 | 65845 | 0.170 |
Why?
|
| Metal Nanoparticles | 1 | 2024 | 191 | 0.170 |
Why?
|
| HeLa Cells | 2 | 2020 | 541 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 323 | 0.160 |
Why?
|
| Carbocyanines | 1 | 2019 | 31 | 0.140 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2019 | 84 | 0.140 |
Why?
|
| Brain | 1 | 2026 | 1672 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2023 | 553 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2026 | 1235 | 0.120 |
Why?
|
| Male | 3 | 2026 | 31410 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 3 | 2023 | 241 | 0.110 |
Why?
|
| Phosphates | 2 | 2026 | 104 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2026 | 1044 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2026 | 1573 | 0.080 |
Why?
|
| Female | 3 | 2026 | 34425 | 0.080 |
Why?
|
| Base Sequence | 2 | 2025 | 1332 | 0.080 |
Why?
|
| Gene Duplication | 1 | 2026 | 35 | 0.060 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2026 | 84 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2026 | 113 | 0.060 |
Why?
|
| Exons | 1 | 2026 | 208 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2026 | 326 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2026 | 173 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2026 | 234 | 0.050 |
Why?
|
| Cell Movement | 1 | 2026 | 484 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2024 | 287 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 292 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2023 | 113 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2023 | 100 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2026 | 1292 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2026 | 588 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2023 | 250 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 369 | 0.040 |
Why?
|
| Gold | 1 | 2024 | 235 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 333 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2020 | 17 | 0.040 |
Why?
|
| Software | 1 | 2024 | 401 | 0.040 |
Why?
|
| Luciferases, Firefly | 1 | 2020 | 19 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2020 | 84 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 136 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 679 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2026 | 2329 | 0.040 |
Why?
|
| Argonaute Proteins | 1 | 2020 | 154 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 314 | 0.030 |
Why?
|
| Lipids | 1 | 2020 | 331 | 0.030 |
Why?
|